D.E. Shaw & Co
CDNA icon

D.E. Shaw & Co’s CareDx CDNA Stock Holding History

D.E. Shaw & Co’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.2M Sell
874,908
-163,578
-16% -$3.1M 0.01% 1331
2025
Q4 		$19.6M Buy
1,038,486
+443,995
+75% +$7.44M 0.01% 1256
2025
Q3 		$8.64M Sell
594,491
-20,883
-3% -$298K ﹤0.01% 1803
2025
Q2 		$12M Sell
615,374
-167,639
-21% -$2.98M 0.01% 1351
2025
Q1 		$13.9M Sell
783,013
-366,215
-32% -$7.89M 0.01% 1161
2024
Q4 		$24.6M Sell
1,149,228
-210,999
-16% -$5.13M 0.02% 914
2024
Q3 		$42.5M Sell
1,360,227
-367,663
-21% -$9.15M 0.04% 593
2024
Q2 		$26.8M Sell
1,727,890
-294,244
-15% -$3.56M 0.03% 736
2024
Q1 		$21.4M Sell
2,022,134
-179,087
-8% -$1.79M 0.02% 892
2023
Q4 		$26.4M Sell
2,201,221
-123,211
-5% -$1.01M 0.02% 773
2023
Q3 		$16.3M Sell
2,324,432
-111,321
-5% -$1.03M 0.02% 970
2023
Q2 		$20.7M Buy
2,435,753
+401,225
+20% +$3.35M 0.02% 850
2023
Q1 		$18.6M Buy
2,034,528
+628,715
+45% +$8.04M 0.02% 945
2022
Q4 		$16M Buy
1,405,813
+530,583
+61% +$7.86M 0.02% 1068
2022
Q3 		$14.9M Buy
875,230
+389,618
+80% +$8.36M 0.02% 1046
2022
Q2 		$10.4M Buy
485,612
+164,129
+51% +$4.55M 0.01% 1357
2022
Q1 		$11.9M Sell
321,483
-147,684
-31% -$5.76M 0.01% 1449
2021
Q4 		$21.3M Sell
469,167
-346,998
-43% -$18.1M 0.02% 1045
2021
Q3 		$51.7M Sell
816,165
-97,462
-11% -$7.42M 0.05% 517
2021
Q2 		$83.6M Sell
913,627
-302,304
-25% -$24M 0.07% 326
2021
Q1 		$82.8M Sell
1,215,931
-12,102
-1% -$940K 0.08% 294
2020
Q4 		$89M Sell
1,228,033
-52,398
-4% -$3.04M 0.08% 303
2020
Q3 		$48.6M Buy
1,280,431
+435,531
+52% +$14.7M 0.05% 431
2020
Q2 		$29.9M Buy
844,900
+165,362
+24% +$4.71M 0.04% 569
2020
Q1 		$14.8M Buy
679,538
+187,105
+38% +$4.19M 0.02% 782
2019
Q4 		$10.6M Sell
492,433
-76,267
-13% -$1.75M 0.01% 1163
2019
Q3 		$12.9M Buy
568,700
+65,601
+13% +$1.82M 0.02% 1011
2019
Q2 		$18.1M Buy
503,099
+349,920
+228% +$11.2M 0.02% 802
2019
Q1 		$4.83M Sell
153,179
-32,297
-17% -$941K 0.01% 1572
2018
Q4 		$4.66M Sell
185,476
-101,976
-35% -$2.62M 0.01% 1562
2018
Q3 		$8.29M Sell
287,452
-261,304
-48% -$4.89M 0.01% 1226
2018
Q2 		$6.72M Buy
+548,756
New +$6.29M 0.01% 1327

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

D.E. Shaw & Co's CDNA Position: Q1 2026 in Review

D.E. Shaw & Co reduced its CareDx (CDNA) stake by 16% in Q1 2026, selling an estimated $3.1M and leaving 874,908 shares worth $15.2M. The position accounts for 0.01% of the portfolio, ranked #1331.

D.E. Shaw & Co first reported a position in CDNA in Q2 2018 and has held it in 32 quarters since. The position peaked at $89M in Q4 2020. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • D.E. Shaw & Co held 874,908 shares of CareDx worth $15.2M as of Q1 2026.
  • D.E. Shaw & Co sold 163,578 CareDx shares in Q1 2026, an estimated $3.1M.
  • CareDx made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1331 holding.
  • D.E. Shaw & Co first reported a position in CareDx in Q2 2018 and has held it in 32 quarters since.
  • D.E. Shaw & Co's CareDx position peaked at $89M in Q4 2020.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.